TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Galecto Stock Soars: Strengthens Blood Cancer Pipeline With Damora Therapeutics Deal, Secures Fresh Funding To 2029

Benzinga Logo Benzinga By Vandana Singh
Galecto Stock Soars: Strengthens Blood Cancer Pipeline With Damora Therapeutics Deal, Secures Fresh Funding To 2029

Galecto Inc. acquired Damora Therapeutics, expanding its blood cancer pipeline and securing $284.9 million in funding through a private placement, with plans to advance multiple therapeutic programs targeting myeloproliferative neoplasms and acute myeloid leukemia.

Insights
NFLX   positive

Emerging as winner in streaming wars, with competitors retreating from the market


GLTO   positive

Stock tripled, secured significant funding, expanded pipeline through strategic acquisition, and received constructive FDA feedback